Azienda Ospedaliero Universitaria Maggiore della Carita clinical trials
Azienda Ospedaliero Universitaria Maggiore della Carita is the lead sponsor of 11 current clinical trials in our Italy and EU (CTIS) registers. 9 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Semaglutide. The most-studied condition is Obesity.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Azienda Ospedaliero Universitaria Maggiore della Carita
10 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Targeting the Hepatic BMP-SMAD Pathway in Leptin Receptor Deficiency (LEPRD)
NCT07833592 · ClinicalTrials.gov ↗ · Leptin Receptor Deficiency Obesity
|
Observational | Recruiting | 2026-09 | Italy |
|
Phenotyping Patients With Type 2 Diabetes Mellitus and Cancer
NCT06299800 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 2, Cancer
|
Observational | Recruiting | 2024-02 | Italy |
|
Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer
NCT06468332 · ClinicalTrials.gov ↗ · Prostate Cancer
|
Observational | Recruiting | 2024-10 | Italy |
|
Development of Smart Food /Nutraceutical Solutions Dedicated to Cardiometabolic Disorders in Ageing
NCT07817290 · ClinicalTrials.gov ↗ · Prediabetes
|
Not applicable | Recruiting | 2025-06 | Italy |
|
European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)
NCT06336187 · ClinicalTrials.gov ↗ · Renal Cell Carcinoma
|
Observational | Recruiting | 2018-06 | Italy |
|
Microparticles Blood Level in Acute Carbon Monoxide Poisoning
NCT05591300 · ClinicalTrials.gov ↗ · Carbon Monoxide Poisoning
|
Observational | Recruiting | 2022-11 | Italy |
|
The ROTAtional-USE of Interface STUDY
NCT05513508 · ClinicalTrials.gov ↗ · Pressure Ulcer, Noninvasive Positive Pressure Ventilation, Acute Hypercapnic Respiratory Failure
|
Not applicable | Recruiting | 2022-12 | Italy |
|
Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity
NCT06438900 · ClinicalTrials.gov ↗ · Sarcopenia, Obesity
|
Observational | Recruiting | 2024-06 | Italy |
|
Susceptibility to Infectious Diseases in Obesity
NCT05975541 · ClinicalTrials.gov ↗ · Obesity, Type2diabetes, Gut Microbiota
|
Observational | Recruiting | 2023-10 | Italy |
|
Effects of VLCKD in Metabolic Syndrome
NCT05275608 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Obesity
|
Not applicable | Active, closed | 2022-11 | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Azienda Ospedaliero Universitaria Maggiore della Carita in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System with Azienda Ospedaliero Universitaria Maggiore della Carita as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
Changes in Coronary Plaque Composition By Semaglutide Use in Diabetic Patients With Acute Coronary Syndrome: A Randomized Optical Coherence Tomography Trial - ARMYDA - 10 study
2025-523977-40-00 · CTIS ↗ · Cardiovascular Diseases
Drug: Semaglutide |
Phase 4 | Authorised | Italy |
Drugs in Azienda Ospedaliero Universitaria Maggiore della Carita trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Azienda Ospedaliero Universitaria Maggiore della Carita trials
17 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 10 | 9 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Obesity
Sponsors with the most current trials registered for this condition.
Questions about Azienda Ospedaliero Universitaria Maggiore della Carita trials
How many clinical trials does Azienda Ospedaliero Universitaria Maggiore della Carita sponsor?
Azienda Ospedaliero Universitaria Maggiore della Carita is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Italy register, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 21 November 2026. Completed and withdrawn studies are not counted.
Are Azienda Ospedaliero Universitaria Maggiore della Carita trials recruiting?
Yes. 9 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Azienda Ospedaliero Universitaria Maggiore della Carita testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Semaglutide (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.